• Home
  1. Home
  2. Inhaled nitric oxide for acute respiratory distress syndrome (ards) in children and adults
Scientific article
English

Inhaled nitric oxide for acute respiratory distress syndrome (ards) in children and adults

ContributorsGebistorf, Fabienne; Karam, Oliver Laurent; Wetterslev, Jørn; Afshari, Arash
Published inCochrane Database of Systematic Reviews, no. 6, CD002787
Publication date2016
Abstract

Acute hypoxaemic respiratory failure (AHRF) and mostly acute respiratory distress syndrome (ARDS) are critical conditions. AHRF results from several systemic conditions and is associated with high mortality and morbidity in individuals of all ages. Inhaled nitric oxide (INO) has been used to improve oxygenation, but its role remains controversial. This Cochrane review was originally published in 2003, and has been updated in 2010 and 2016.

Keywords
  • Acute Disease
  • Acute Lung Injury/drug therapy/mortality
  • Administration
  • Inhalation
  • Adult
  • Child
  • Humans
  • Hypoxia/drug therapy/mortality
  • Length of Stay
  • Nitric Oxide/administration & dosage/adverse effects
  • Randomized Controlled Trials as Topic
  • Respiratory Distress Syndrome
  • Adult/drug therapy/mortality
  • Respiratory Insufficiency/drug therapy/mortality
  • Vasodilator Agents/adverse effects/therapeutic use
Affiliation entities
Research groups
Citation (ISO format)
GEBISTORF, Fabienne et al. Inhaled nitric oxide for acute respiratory distress syndrome (ards) in children and adults. In: Cochrane Database of Systematic Reviews, 2016, n° 6, p. CD002787. doi: 10.1002/14651858.CD002787.pub3
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1469-493X
538views
0downloads

Technical informations

Creation14/09/2017 17:02:00
First validation14/09/2017 17:02:00
Update15/03/2023 02:00:40
Status update15/03/2023 02:00:40
Last indexation31/10/2024 07:45:37
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack